Aurobindo Pharma Limited (NSE:AUROPHARMA) Directors Insider Transactions
The Directors and Chief Executives of Aurobindo Pharma Limited (NSE:AUROPHARMA) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Aurobindo Pharma Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Aurobindo Pharma Limited to the NSE stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Aurobindo Pharma Limited Directors/Insider Transactions Activity
List of Insider trades activity from Aurobindo Pharma Limited (AUROPHARMA).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 12 Sep 2024 | Life Insurance Corporation of India | Institution- Corporation | 4,326,446 | - | - |
| 07 Jun 2024 | Kambam (Kirthi Reddy) | Promoter | 200,000 | - | - |
| 22 Mar 2024 | Kamath (Janardhana A) | UNREPORTED | 6,000 | 72,753 | Sale at price 12.13 per share. |
| 29 Feb 2024 | PS (Pavankumar) | UNREPORTED | 1,000 | 12,328 | Sale at price 12.33 per share. |
| 27 Feb 2024 | Kandati (Chandrasekhar Reddy) | UNREPORTED | 2,000 | 25,275 | Sale at price 12.64 per share. |